Supply Of Environmentally Friendly Medicines For Human Use That Contain The Active Ingredients, Osimertinib, Benralizumab, Olaparib, Acalabrutinib, Anifrolumab, Tezepelumab Marketed By A Single Laboratory, Through The Negotiated Procedure Without Advertising Due To Exclusivity, Destined For The Valencian Public Health Centers.

Direccion General de Gestion Economica, Contratacion e Infraestructuras de la Conselleria de Sanidad Spain has Released a tender for Supply Of Environmentally Friendly Medicines For Human Use That Contain The Active Ingredients, Osimertinib, Benralizumab, Olaparib, Acalabrutinib, Anifrolumab, Tezepelumab Marketed By A Single Laboratory, Through The Negotiated Procedure Without Advertising Due To Exclusivity, Destined For The Valencian Public Health Centers. in Pharmaceuticals. The tender was released on Oct 13, 2025.

Country - Spain

Summary - Supply Of Environmentally Friendly Medicines For Human Use That Contain The Active Ingredients, Osimertinib, Benralizumab, Olaparib, Acalabrutinib, Anifrolumab, Tezepelumab Marketed By A Single Laboratory, Through The Negotiated Procedure Without Advertising Due To Exclusivity, Destined For The Valencian Public Health Centers.

Deadline - login to view

GT reference number - 120066804

Product classification - Medicinal products for obstructive airway diseases